Levels of CXCL4 were elevated in patients with systemic sclerosis and correlated with the presence and progression of complications, such as lung fibrosis and pulmonary arterial hypertension. The New England Journal of Medicine, 12/18/2013. (Also see: Biomarkers, Pulmonary Hypertension and Pulmonary Fibrosis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.